Document Detail


Early mobilization after diagnostic cardiac catheterization with the use of a hemostatic bandage containing thrombin.
MedLine Citation:
PMID:  16757402     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of the present study was to assess the efficacy and safety of a thrombin-containing bandage for local hemostasis after femoral sheath removal in patients undergoing diagnostic cardiac catheterization. Forty-one patients undergoing diagnostic coronary angiography using a 6-F femoral sheath were included. The sheath was removed immediately after the procedure using the bandage according to a prespecified protocol. Mean compression time was 7.3+/-1.7 min and mean time from sheath removal to mobilization was 132+/-34 min. None of the patients suffered recurrent bleeding or any in-hospital and 7-day vascular complications. We conclude that in patients undergoing femoral-access diagnostic cardiac catheterization, the use of a hemostatic bandage containing thrombin was associated with short time to hemostasis with the ability for early patient mobilization without vascular complications.
Authors:
Dan Elian; Victor Guetta; Rony Alcalai; Chaim Lotan; Amit Segev
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiovascular revascularization medicine : including molecular interventions     Volume:  7     ISSN:  1553-8389     ISO Abbreviation:  -     Publication Date:    2006 Apr-Jun
Date Detail:
Created Date:  2006-06-07     Completed Date:  2006-10-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101238551     Medline TA:  Cardiovasc Revasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  61-3     Citation Subset:  IM    
Affiliation:
Interventional Cardiology Unit, The Heart Institute, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bandages* / adverse effects
Early Ambulation*
Heart Catheterization*
Hemostatic Techniques* / adverse effects
Humans
Thrombin / administration & dosage*,  therapeutic use
Wound Healing / physiology
Chemical
Reg. No./Substance:
EC 3.4.21.5/Thrombin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Insulin resistance in nondiabetic patients with acute myocardial infarction.
Next Document:  Apparent racial disparity in the utilization of invasive testing for risk assessment of cardiac pati...